The GBD advantage

Four key benefits will maximize the study's utility as both a source of accurate knowledge and a vital tool for informed decision-making.

Evidence-based evaluations

The GBD separates epidemiological assessment from advocacy, creating evidence-based pictures of patterns in health that can subsequently motivate responsible policy and research. Major causes of infectious disease like HIV, TB, and malaria have absorbed a great deal of analytical attention while "new" conditions, like hearing loss and migraine, have recently been brought to the public health agenda. The new GBD will use standard measures to ensure that all conditions receive systematic, objective analysis.

Changing awareness and validity of different global health conditions

The GBD combines information on causes of premature mortality, morbidity, and disability to present a balanced assessment of health problems. The first study brought visibility and legitimacy to conditions like depression and paralysis, which cause great suffering with little associated mortality, and to conditions like road traffic accidents, which were formerly outside the scope of public health. The new study has the potential to change perceptions of global health again in ways that cannot be anticipated yet.

Cost-effectiveness analysis

The GBD assesses the magnitude of health problems using standard units of measurement, such as disability-adjusted life years (DALYs). This study feature allows for lives in every part of the world to be valued equally and creates a common unit of currency for making decisions about the costs and benefits of various health interventions.

Engaging researchers, experts, and policymakers

Finally, the study will focus from the outset on education, training, and transparency, incorporating features like an interactive website where experts can post information and actively discuss the study process. Broadening the global community's engagement with health metrics will be a focal point of the project.